20.42.Z - Manufacture of perfumes and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
32.50.Z - Manufacture of medical and dental instruments and supplies
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
47.91.Z - Retail sale via mail order houses or via Internet
47.99.Z - Other retail sale not in stores, stalls or markets
58.11.Z - Book publishing
58.19.Z - Other publishing activities
62.01.Z - Computer programming activities
62.09.Z - Other information technology and computer service activities
63.12.Z - Web portals
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
74.10.Z - Specialised design activities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
84.12.Z - Regulation of the activities of providing health care, education, cultural services and other social services, excluding social security
85.59.B - Other out-of-school forms of education, not elsewhere classified
85.60.Z - Educational support activities
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.90.E - Other human health activities notelsewhere classified
2019 | 2020 | 2021 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -168,6 | -53,4 | -203,1 | -280,2 |
EBITDA | -109,4 | -39,3 | -162,4 | -313,3 |
Short time liabilities | 157,5 | 223,5 | 468,8 | 109,8 |
Equity capital | -29,8 | -83,2 | -286,3 | -244 |
Operating profit (EBIT) | -162 | -56,8 | -201,9 | -255,2 |
Assets | 233,2 | 206,4 | 210,4 | 2 |
Net profit (loss) | -168,6 | -53,4 | -203,1 | -280,2 |
Cash | 1,4 | 20,9 | 3,4 | -83,7 |
Liabilities and provisions for liabilities | 263 | 289,6 | 496,7 | 71,5 |
Net income from sale | 133,6 | 115,4 | 130,9 | 13,4 |
Working assets | 60,6 | 121,7 | 165,3 | 35,8 |
Depreciation | 52,6 | 17,5 | 39,5 | 125,2 |
% | % | % | p.p. | |
Profitability of capital | 565,7 | 64,2 | 70,9 | 6,7 |
Equity capital to total assets | -12,8 | -40,3 | -136,1 | -95,8 |
Gross profit margin | -126,2 | -46,3 | -155,1 | -108,8 |
EBITDA Margin | -81,8 | -34 | -124 | -90 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 430 | 706 | 1307 | 601 |
Current financial liquidity indicator | 0.38515347242355347 | 0.5447830557823181 | 0.35267090797424316 | -0,1 |
Net dept to EBITDA | -1.7105662822723389 | -4.913069725036621 | -2.827617883682251 | 2,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane